{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:sobhan-pharmaceutical-company",
    "identifier": "hg:company:sobhan-pharmaceutical-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:16+00:00",
    "name": "Sobhan Pharmaceutical Company",
    "slug": "sobhan-pharmaceutical-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/sobhan-pharmaceutical-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/sobhan-pharmaceutical-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/sobhan-pharmaceutical-company",
    "summary": "",
    "machine_summary": "Sobhan Pharmaceutical Company Sobhan Pharmaceutical Company is a pharmaceutical manufacturer associated with Rasht and Gilan’s industrial healthcare base. Its relevance comes from supplying medicine into Iran’s regulated healthcare market, where demand is relatively defensive but constrained by pricing rules, raw-material access, technology requirements, and supply-shortage risk. For Hormuz Group, Sobhan helps map the manufacturing layer of Iran’s pharmaceutical sector outside Tehran’s holding-company center and beyond the largest national drug groups. In the Hormuz investment graph, Sobhan Pharmaceutical Company connects pharmaceutical manufacturing, healthcare consumption, raw-material imports, regional industrial capacity, quality-control systems, and medicine availability. It is useful for screening domestic drug-production resilience, supplier opportunities, healthcare-sector demand, and supply-chain exposure in northern Iran. Foreign-facing analysis should verify exact product portfolio, manufacturing licenses, disclosure data, raw-material sourcing, export activity, regulatory obligations, compliance risk, and counterparty reliability before commercial reliance. Sobhan Pharmaceutical Company is associated with pharmaceutical manufacturing, including finished medicines and healthcare products serving prescription, consumer, and specialized therapeutic demand. Its operating profile links Gilan’s industrial base, medicine supply chains, regulated healthcare demand, raw-material access, quality-control requirements, and domestic pharmaceutical production under import and technology constraints. province: Gilan industry: Healthcare & Pharma, Manufacturing, Pharmaceuticals market: Consumer Demand, Healthcare, Materials, Supply Chains challenges: Compliance, Import Dependence, Supply Shortage, Technology Gap company_type: Manufacturer, Public Company city: Rasht",
    "published_at": "2026-06-28T18:12:53+00:00",
    "modified_at": "2026-06-28T18:12:53+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 192,
                "name": "Gilan",
                "slug": "gilan",
                "url": "https://hormuz.group/provinces/gilan/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 16,
                "name": "Manufacturing",
                "slug": "manufacturing",
                "url": "https://hormuz.group/industry/manufacturing/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 73,
                "name": "Materials",
                "slug": "materials",
                "url": "https://hormuz.group/market/enterprise-demand/materials/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            },
            {
                "id": 179,
                "name": "Technology Gap",
                "slug": "technology-gap",
                "url": "https://hormuz.group/challenges/market-gaps/technology-gap/"
            }
        ],
        "company_type": [
            {
                "id": 299,
                "name": "Manufacturer",
                "slug": "manufacturer",
                "url": "https://hormuz.group/company-type/manufacturer/"
            },
            {
                "id": 306,
                "name": "Public Company",
                "slug": "public-company",
                "url": "https://hormuz.group/company-type/public-company/"
            }
        ],
        "city": [
            {
                "id": 478,
                "name": "Rasht",
                "slug": "rasht",
                "url": "https://hormuz.group/cities/rasht/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Gilan",
        "industry": "Healthcare & Pharma, Manufacturing, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Materials, Supply Chains",
        "challenges": "Compliance, Import Dependence, Supply Shortage, Technology Gap",
        "company_type": "Manufacturer, Public Company",
        "city": "Rasht"
    },
    "fields_summary": {
        "legal_name": "Sobhan Pharmaceutical Company",
        "website": "https://sobhanpharma.com",
        "city": "Rasht, Gilan Province, Iran",
        "ticker_symbol": "دسبحا",
        "listing_status": "listed_tse",
        "products_services": "Sobhan Pharmaceutical Company is associated with pharmaceutical manufacturing, including finished medicines and healthcare products serving prescription, consumer, and specialized therapeutic demand. Its operating profile links Gilan’s industrial base, medicine supply chains, regulated healthcare demand, raw-material access, quality-control requirements, and domestic pharmaceutical production under import and technology constraints.",
        "export_relevance": "low",
        "short_profile": "Sobhan Pharmaceutical Company is a pharmaceutical manufacturer associated with Rasht and Gilan’s industrial healthcare base. Its relevance comes from supplying medicine into Iran’s regulated healthcare market, where demand is relatively defensive but constrained by pricing rules, raw-material access, technology requirements, and supply-shortage risk. For Hormuz Group, Sobhan helps map the manufacturing layer of Iran’s pharmaceutical sector outside Tehran’s holding-company center and beyond the largest national drug groups.",
        "investment_relevance": "In the Hormuz investment graph, Sobhan Pharmaceutical Company connects pharmaceutical manufacturing, healthcare consumption, raw-material imports, regional industrial capacity, quality-control systems, and medicine availability. It is useful for screening domestic drug-production resilience, supplier opportunities, healthcare-sector demand, and supply-chain exposure in northern Iran. Foreign-facing analysis should verify exact product portfolio, manufacturing licenses, disclosure data, raw-material sourcing, export activity, regulatory obligations, compliance risk, and counterparty reliability before commercial reliance."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Sobhan Pharmaceutical Company",
        "city": "Rasht, Gilan Province, Iran",
        "ticker_symbol": "دسبحا",
        "export_relevance": "low",
        "verification_status": "basic",
        "data_confidence": "medium",
        "listing_status": "listed_tse",
        "last_updated": "28/06/2026",
        "website": "https://sobhanpharma.com",
        "products_services": "Sobhan Pharmaceutical Company is associated with pharmaceutical manufacturing, including finished medicines and healthcare products serving prescription, consumer, and specialized therapeutic demand. Its operating profile links Gilan’s industrial base, medicine supply chains, regulated healthcare demand, raw-material access, quality-control requirements, and domestic pharmaceutical production under import and technology constraints.",
        "short_profile": "Sobhan Pharmaceutical Company is a pharmaceutical manufacturer associated with Rasht and Gilan’s industrial healthcare base. Its relevance comes from supplying medicine into Iran’s regulated healthcare market, where demand is relatively defensive but constrained by pricing rules, raw-material access, technology requirements, and supply-shortage risk. For Hormuz Group, Sobhan helps map the manufacturing layer of Iran’s pharmaceutical sector outside Tehran’s holding-company center and beyond the largest national drug groups.",
        "investment_relevance": "In the Hormuz investment graph, Sobhan Pharmaceutical Company connects pharmaceutical manufacturing, healthcare consumption, raw-material imports, regional industrial capacity, quality-control systems, and medicine availability. It is useful for screening domestic drug-production resilience, supplier opportunities, healthcare-sector demand, and supply-chain exposure in northern Iran. Foreign-facing analysis should verify exact product portfolio, manufacturing licenses, disclosure data, raw-material sourcing, export activity, regulatory obligations, compliance risk, and counterparty reliability before commercial reliance.",
        "source_note": "Based on public company, market, sector, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 27
        },
        "ticker_symbol": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 3
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 6
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 24
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 438
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 536
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 628
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 175
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, market, sector, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "medium",
        "last_updated": "28/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "medium",
        "last_updated": "28/06/2026"
    }
}